A nonrandomized phase II study of dose-dense paclitaxel and cyclophosphamide (PC) in early-stage breast cancer (EBC).

Kailash Mosalpuria; Ryan C. Ramaekers; Mehmet Sitki Copur; Kenneth H. Cowan; Mary Mailliard; Elizabeth Lyden; Wajeeha Razaq; Elizabeth C. Reed

doi:10.1200/jco.2014.32.15_suppl.e11588

A nonrandomized phase II study of dose-dense paclitaxel and cyclophosphamide (PC) in early-stage breast cancer (EBC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e11588 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e11588-e11588

Author(s):

Kailash Mosalpuria ◽

Ryan C. Ramaekers ◽

Mehmet Sitki Copur ◽

Kenneth H. Cowan ◽

Mary Mailliard ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Dose Dense

Download Full-text

Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer

The Breast Journal ◽

10.1111/tbj.12951 ◽

2018 ◽

Vol 24 (3) ◽

pp. 260-268 ◽

Cited By ~ 2

Author(s):

Aleli Campbell ◽

Rosalinda Heydarian ◽

Cecilia Ochoa ◽

Alok Kumar Dwivedi ◽

Zeina A. Nahleh

Keyword(s):

Breast Cancer ◽

Vitamin B12 ◽

Phase Ii ◽

Aromatase Inhibitors ◽

Phase Ii Study ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Musculoskeletal Symptoms ◽

Oral Vitamin

Download Full-text

A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer

Investigational New Drugs ◽

10.1007/s10637-013-9973-4 ◽

2013 ◽

Vol 31 (5) ◽

pp. 1300-1306 ◽

Cited By ~ 18

Author(s):

K. H. Park ◽

J. H. Sohn ◽

S. Lee ◽

J. H. Park ◽

S. Y. Kang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Open Label ◽

Tac Chemotherapy ◽

Open Label Phase

Download Full-text

Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.01.091 ◽

2012 ◽

Vol 84 (4) ◽

pp. 888-893 ◽

Cited By ~ 31

Author(s):

Gary M. Freedman ◽

Penny R. Anderson ◽

Richard J. Bleicher ◽

Samuel Litwin ◽

Tianyu Li ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase Ii ◽

Local Control ◽

Phase Ii Study ◽

Early Stage ◽

Intensity Modulated Radiation Therapy ◽

Early Stage Breast Cancer ◽

Intensity Modulated

Download Full-text

Abstract OT2-3-04: A PILOT PHASE II STUDY TO EVALUATE THE IMPACT OF DENOSUMAB ON DISSEMINATED TUMOR CELLS (DTC) IN PATIENTS WITH EARLY STAGE BREAST CANCER (ESBC)

10.1158/0008-5472.sabcs12-ot2-3-04 ◽

2012 ◽

Author(s):

J Li ◽

HS Rugo

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Phase Ii ◽

Phase Ii Study ◽

Early Stage ◽

Disseminated Tumor Cells ◽

Early Stage Breast Cancer ◽

Pilot Phase ◽

The Impact

Download Full-text

Phase II study of a 3-weekly liposome-encapsulated doxorubicin/docetaxel/pegfligrastrim in combination with weekly trastuzumab as primary treatment in HER2 positive early stage breast cancer patients (II-IIIa). GEICAM 2003-03 study.

10.1158/0008-5472.sabcs-5117 ◽

2009 ◽

Author(s):

A Anton ◽

A Ruiz-Simon ◽

A Plazaola ◽

L Calvo ◽

M Segui ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Early Stage ◽

Primary Treatment ◽

Early Stage Breast Cancer ◽

Breast Cancer Patients ◽

Her2 Positive

Download Full-text

A Phase II Study of Vaginal Testosterone Cream (TEST) vs. Estring for Vaginal Dryness or Decreased Libido in Women with Early Stage Breast Cancer (BC) Treated with Aromatase Inhibitors (AIs).

10.1158/0008-5472.sabcs-09-5038 ◽

2009 ◽

Cited By ~ 2

Author(s):

M. Melisko ◽

H. Rugo ◽

A. DeLuca ◽

J. Park ◽

M. Moasser ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Aromatase Inhibitors ◽

Phase Ii Study ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Vaginal Dryness

Download Full-text

Nolan: A randomized, phase II study to estimate the effect of prophylactic naproxen (N) or loratadine (L) vs no intervention on bone pain in 600 patients (pts) with early-stage breast cancer receiving chemotherapy (chemo) and pegfilgrastim (PEG).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.10021 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 10021-10021 ◽

Cited By ~ 1

Author(s):

Jeffrey J. Kirshner ◽

Andrew S Guinigundo ◽

Linda Vanni ◽

Cathy L Maxwell ◽

Maureen Reiner ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Bone Pain ◽

Phase Ii Study ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Randomized Phase Ii

Download Full-text

A Prospective, Belgian Multi-center, Single-arm, Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04224922 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Study ◽

Stage Ii ◽

Weekly Paclitaxel ◽

Dose Dense

Download Full-text

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-0443 ◽

2019 ◽

Vol 26 (1) ◽

pp. 25-34 ◽

Cited By ~ 3

Author(s):

Oukseub Lee ◽

Megan E. Sullivan ◽

Yanfei Xu ◽

Chiara Rogers ◽

Miguel Muzzio ◽

...

Keyword(s):

Breast Cancer ◽

Progesterone Receptor ◽

Phase Ii ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Window Of Opportunity ◽

Receptor Modulators ◽

Selective Progesterone Receptor Modulators ◽

Progesterone Receptor Modulators

Download Full-text

0152 Dose-dense nab-paclitaxel vs paclitaxel with bevacizumab following adriamycin and cytoxan is safe as adjuvant therapy in patients with early-stage breast cancer

The Breast ◽

10.1016/s0960-9776(09)70183-3 ◽

2009 ◽

Vol 18 ◽

pp. S57

Author(s):

J. Pippen ◽

D. Paul ◽

D. Richards ◽

P. Bhar ◽

J. Iglesias

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Dose Dense

Download Full-text